GSK Consumer Healthcare is at the forefront of innovation in oral care and in fostering oral health education with the aim of helping billions of people around the world to achieve better oral health.

GSK’s oral treatment Jesduvroq increases erythropoietin ... or injected recombinant human erythropoietin (a standard of care treatment for patients with anaemia due to CKD).

Primary care studies have ... related to AMR by 2030. GSK, meanwhile, has also completed another phase 3 trial of gepotidacin, called EAGLE-1, which showed that two oral doses of the drug were ...